It's time to shift some of the attention paid to lipid-lowering drugs onto therapies that fight vascular inflammation, according to a number of experts speaking on the opening day of the European Society of Cardiology (ESC) 2012 Congress. Statin and aspirin studies tracking markers of inflammation show that "the magnitude of this disease associated with inflammation is at least as large as that of lipids or blood pressure," Dr Paul Ridker (Brigham and Women's Hospital, Boston, MA) told heartwirehere.Still think they have any idea what they are talking about?
Fitness - the only REAL preventive medicine. tm
Get fit.
Posts
No comments:
Post a Comment